BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer

BACKGROUND: Mutations in BRCA1 and BRCA2 are associated with better survival in ovarian cancer (OC) patients due to a better response to platinum-based chemotherapy. However, the impact of the BRCA1/2 mRNA-expression is not well characterized in OC. PATIENTS AND METHODS: We investigated BRCA1/2 mRNA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Tsibulak, Irina, Wieser, Verena, Degasper, Christine, Shivalingaiah, Giridhar, Wenzel, Sören, Sprung, Susanne, Lax, Sigurd F., Marth, Christian, Fiegl, Heidelinde, Zeimet, Alain G.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6173779/
https://ncbi.nlm.nih.gov/pubmed/30111871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0217-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados